Rivaroxaban, marketed by Bayer under the brand name Xarelto®, is a popular oral prescription blood-thinning drug. Xarelto® was first approved by the U.S. Food and Drug Administration in 2011, and by all accounts, Xarelto® has been a blockbuster drug for Bayer. Despite the success and popularity of Xarelto®, there have been many reports of serious adverse events in patients taking the drug. The lawsuits involving Xarelto® allege that the manufacturer of the drug failed to warn doctors and patients that the drug could cause irreversible internal bleeding and that a substitute medication was just as effective at reducing clots but without the life-threatening danger of excessive blood loss.
For more than 50 years doctors have prescribed Warfarin (marketed under the brand name Coumadin®) for patients who suffer from atrial fibrillation to reduce the risk of blood clots and strokes in these patients. Over the past decade, drug manufacturers have developed other drugs, like Xarelto®, to try and gain a market share of this industry. Like Eliquis® and Pradaxa®, Xarelto® belongs to a new family of anticoagulants that do not have a reversal agent, or antidote, to stop the drugs’ blood-thinning effects in the event of a serious bleeding event. Warfarin has an antidote that can be administered to a patient taking the drug if that patient develops a serious bleed, and the antidote immediately negates the blood-thinning effects of the drug. The severe bleed can then be treated and the patient’s blood will clot. Since Xarelto® does not have an antidote, when a patient taking the drug has a severe bleeding event, nothing can be done to make the blood clot to stop the bleed. This can result in serious injury or even death, particularly when the bleeding event occurs internally.
The attorneys at Franklin D. Azar and Associates are investigating the following Xarelto® side effects:
- Blood Clots
- Gastrointestinal Bleeding
- Rectal Bleeding
- Kidney Bleeding
- Hemorrhagic Stroke (Brain Bleeding)
- Intracranial Bleeding (Bleeding in the Skull)
- Uncontrollable bleeding
- Infection Following Hip or Knee Replacement Surgery
- Decreased Hemoglobin Levels
- Hematoma (a Swelling of Clotted Blood in the Tissue)
- Peripheral Edema (Swelling of the Lower Limbs)